Navigation Links
Cumberland Pharmaceuticals Reports 2011 Annual Financial Results
Date:2/29/2012

equivalents$
70,599,146$   65,893,970Accounts receivable, net of allowances7,082,8905,145,494Inventories5,774,6947,683,842Prepaid and other current assets1,627,4551,336,765Deferred tax assets2,223,882978,771Total current assets87,308,06781,038,842Property and equipment, net1,119,3391,220,010Intangible assets, net7,023,0647,427,223Deferred tax assets-2,265,192Other assets67,846102,787Total assets$
95,518,316$   92,054,054LIABILITIES AND EQUITYCurrent liabilities:Current portion of long-term debt$
-$
2,666,668Accounts payable1,513,5482,124,654Other accrued liabilities5,086,4004,436,298Total current liabilities6,599,9489,227,620Revolving line of credit4,859,9511,825,951Long-term debt, excluding current portion -2,666,665Deferred tax liability645,029-Other long-term obligations, excluding current portion 578,119618,343Total liabilities12,683,04714,338,579Commitments and contingenciesEquity:Shareholders' equity:Common stock – no par value; 100,000,000 shares authorized; 20,020,535 and 20,338,461shares issued and outstanding as of December 31, 2011 and 2010, respectively 70,272,15570,778,874Retained earnings12,656,6626,998,806Total shareholders' equity82,928,81777,777,680Noncontrolling interests(93,548)(62,205)Total equity82,835,26977,715,475Total liabilities and equity$
95,518,316$   92,054,054CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIESCondensed Consolidated Statements of Income(Unaudited)Years ended December 31, 2011, 2010 and 2009201120102009Revenues:Net product revenue$   50,893,794$   44,704,570$   43,142,350Other revenue248,9821,171,801394,928Net revenues51,142,77645,876,37143,537,278Costs and expenses:Cost of products sold5,362,5543,586,6464,136,541Selling and marketing20,940,06022,674,50520,194,074Research and development5,028,0724,327,4854,993,278General and administrative9,197,9557,990,2227,643,070Amortization655,302686,911686,904Other109,346108,855106,776Total costs and expenses41,293,28939,374,62437,760,6
'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
3. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
4. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
5. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
6. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
7. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
8. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
9. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
10. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
11. Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...  A Boston Scientific Corporation (NYSE: ... and preliminary long term stricture resolution of benign ... issue of the peer-reviewed journal, Gastroenterology. ... conducted in 11 countries and five continents, and ... (FCSEMS) after extended indwell (i.e., up to 12 ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "China Orthopedic Instrument Industry Report, 2014-2017" report to ... population and rising proportion of reimbursement for medical expenses, ... released, with its scale presenting a CAGR of 19.2% ... are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Research and Development Trend Forecast of Pharmaceutical ... offering. Research and Development Trend Forecast ... , 2014-2018 mainly analyzes China,s ... status, supply & demand, competition landscape, and business performance ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4China Orthopedic Instrument Industry Report, 2014-2017 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... that it received $2.5 million from AstraZeneca AB pursuant to the September 2009 amendment of the exclusive ... indications. , ... , ... ...
... , ... ... - Spasticity Affects a Significant Number of Post-Stroke Patients,[1],[2],[3] and Many are not Adequately Treated by Standard Therapy [4] , ... , , ...
Cached Medicine Technology:Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca 2First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 2First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 3First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 4First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 5First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 6First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 7First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 8First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 9
(Date:9/1/2014)... By Dennis Thompson ... -- An experimental Ebola drug previously given to two American ... the deadly virus in laboratory tests, researchers report. The ... it, even if they didn,t get the medication until five ... cases of Ebola who were days or even hours away ...
(Date:9/1/2014)... As well as having completed the Non ... counselor certification in Louisiana. , "I have ... program as well as the Counselor training program ... and professionally. I am not only dedicated to ... do so. As a Non Violent Crisis Intervention ...
(Date:9/1/2014)... Albany, New York (PRWEB) September 01, 2014 ... to store, retrieve, organize and analyze biological and ... comprises of the activity of developing software tools ... is not to be confused with biological computation. ... the better understanding of biology can its related ...
(Date:9/1/2014)... 01, 2014 Registration is now open for ... and 1-Mile Race to be held on Sunday, September 21, ... Yard at Harmon Meadow in Secaucus, New Jersey. All proceeds ... national nonprofit dedicated to restoring a sense of self, restoring ... and our military families. , General registration is $30 with ...
(Date:9/1/2014)... Daily Gossip reveals in it's review ... that gives members access to thousands of professionally designed ... resource aims to help both people who plan on ... are looking for inspiration in creating one of a ... Now by visiting the official website at: http://www.dailygossip.org/atattoo-me-now-6444 ...
Breaking Medicine News(10 mins):Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2
... of jaundice were detected here today even as health ... be suffering from the disease. // ,Officials ... found four persons including two children were suffering from ... civil surgeon visited the area as doctors collected blood ...
... doctors in Toronto are desperately trying to reattach the foot of ... freak accident that involved his father // riding over him on ... boys father had been riding a lawn mower when the boy ... father had put the mower into reverse and accidentally ran over ...
... women will have a vaccine to protect themselves from cervical ... 'Gardasil' produced by American pharmaceutical giant Merck. // ... the vaccine, Gardasil, for use in girls and women ages ... an early release of products with potential to provide significant ...
... soon launch a Rs 350 crore Integrated Disease Surveillance ... throughout the country. // ,Union Health minister ... Bank-funded project would be able to create a veritable ... cardio-vascular diseases and even road accidents., ,'This will ...
... Recent research has revealed that taking antibiotics for three days ... is equally effective in the treatment of common pneumonia // ... to curb the rising problem of antibiotic-resistant bacteria, ... diseases at the Academic Medical Center, in Amsterdam said,’The question ...
... the death toll was so overwhelming that steam shovels were ... //memorial services, trains commandeered to transport dead soldiers and priests ... ,With the threat of another flu pandemic looming in the ... providers making preparations for it mortuary specialists are once more ...
Cached Medicine News:Health News:Pneumonia Effectively Treated with Short-Term Antibiotic Course 2Health News:What to do with the Dead if a Flu Outbreak Happens? 2
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Girard straight tying forceps made of titanium has straight shafts with 6 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 105 mm....
McPherson curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 85 mm....
McPherson straight tying forceps made of titanium, straight shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 87 mm....
Medicine Products: